Cite
HARVARD Citation
Gremida, A. et al. (2021). A New Way to Assess the Trajectory of Remission in Crohn Disease: Correlating Drug Levels With a Noninvasive Blood Biomarker of Mucosal Remission. Crohn's & colitis 360. 3 (3), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Gremida, A. et al. (2021). A New Way to Assess the Trajectory of Remission in Crohn Disease: Correlating Drug Levels With a Noninvasive Blood Biomarker of Mucosal Remission. Crohn's & colitis 360. 3 (3), p. . [Online].